What is the catalog number for BRG1 Rabbit Monoclonal Antibody?

The catalog number for BRG1 Rabbit Monoclonal Antibody is orb547166.

What sizes are available for BRG1 Rabbit Monoclonal Antibody?

BRG1 Rabbit Monoclonal Antibody is available in the following size(s): 100 µL.

Is BRG1 Rabbit Monoclonal Antibody in stock?

BRG1 Rabbit Monoclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

BRG1 Rabbit Monoclonal Antibody

Anti-BRG1 Rabbit Monoclonal Antibody. Tested in WB, IHC, ICC/IF, IP applications. This antibody reacts with Human, Mouse, Rat.

Product Specifications

Product Name Alternative

Transcription activator BRG1; 3.6.4.-; ATP-dependent helicase SMARCA4; BRG1-associated factor 190A; BAF190A; Mitotic growth and transcription activator; Protein BRG-1; Protein brahma homolog 1; SNF2-beta; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4; SMARCA4; BAF190A, BRG1, SNF2B, SNF2L4

UniProt

P51532

Reactivity

Human, Mouse, Rat

Immunogen

A synthesized peptide derived from human BRG1

Target

SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4

Clonality

Monoclonal

Clone

BIHDX31

Conjugation

Unconjugated

Field of Research

Epigenetics & Chromatin, Neuroscience

Purification

Affinity-chromatography

Concentration

0.5mg/ml

Dilution

WB 1:1000-5000 IHC 1:50-200 ICC/IF 1:50-200 IP 1:20

Form

Liquid

Molecular Weight

220 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

ICC, IF, IHC, IP, WB

Host or Source

Rabbit

Preservative

Rabbit IgG in stabilizing components, phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.